In this episode, we take a look at a company that’s on a mission to get safe, natural psychedelics into the hands of everyone who needs them, as soon as possible. Filament Health (FH.NEO) is an exclusively natural psychedelic drug development company and received the first-ever psilocybin extraction and standardization patent for a public company by the Canadian Intellectual Property Office. We analyze Filament’s future potential in the industry. Tune in!
Filament Health (FH.NEO) Leading the way in Natural Psychedelics. But Is it a Good Long Term Investment?
Latest Articles
- Rex Resources (OWN.V) continues gearing up with BC gold property
- Saga Metals (SAGA.V) investors get a mature resource explorer with a ‘weak hands’ discount
- The Plurilock (PLUR.V) rip is over: But is that the end of the play?
- The unknown mining property that holds nickel copper, platinum… and uranium?
- Sparc AI: Revolutionizing Drone Technology with GPS-Free Autonomous Flight
Top Searches
Abitibi Greenstone Belt Barrick Gold best canadian cannabis company biotech Bitcoin blockchain bullion California Canada cannabis CBD China Chris Parry covid cryptocurrency DEFN.V Fraser Institute gambling Gold gold price. gold prices Greg Nolan hemp inflation interest rates investing investments Lukas Kane marijuana mining money Newmont Goldcorp Nexus Gold pharmaceuticals psychedelics resources shrooms stock market stocks technology trading uranium wealth wealth creation weed
Leave a Reply